Build Your Comparison

Side-by-side financial analysis
ABVX logo
ABVX
ARRY logo
ARRY
KO logo
KO
Try popular comparisons:

Stock Comparison

ABVX vs ARRY vs KO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ABVX
Abivax S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$6.61B
5Y Perf.+949.5%
ARRY
Array Technologies, Inc.

Solar

EnergyNASDAQ • US
Market Cap$1.15B
5Y Perf.-47.6%
KO
The Coca-Cola Company

Beverages - Non-Alcoholic

Consumer DefensiveNYSE • US
Market Cap$355.22B
5Y Perf.+39.9%

ABVX vs ARRY vs KO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ABVX logoABVX
ARRY logoARRY
KO logoKO
IndustryBiotechnologySolarBeverages - Non-Alcoholic
Market Cap$6.61B$1.15B$355.22B
Revenue (TTM)$0.00$1.21B$49.28B
Net Income (TTM)$-427M$-67M$13.70B
Gross Margin23.0%61.7%
Operating Margin4.5%29.3%
Forward P/E10.2x25.2x
Total Debt$32M$766M$45.49B
Cash & Equiv.$516M$244M$10.27B

ABVX vs ARRY vs KOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ABVX
ARRY
KO
StockOct 23Jun 26Return
Abivax S.A. (ABVX)1001049.5+949.5%
Array Technologies,… (ARRY)10052.4-47.6%
The Coca-Cola Compa… (KO)100139.9+39.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: ABVX vs ARRY vs KO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: KO leads in 3 of 7 categories, making it the strongest pick for profitability and margin quality and dividend income and shareholder returns. Abivax S.A. is the stronger pick specifically for capital preservation and lower volatility and recent price momentum and sentiment. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
🥇KO emerged as the overall leader. Track its performance:
ABVX
Abivax S.A.
The Income Pick

ABVX is the clearest fit if your priority is income & stability and long-term compounding.

  • beta 1.02
  • 11.2% 10Y total return vs KO's 120.9%
  • Lower volatility, beta 1.02, Low D/E 7.1%, current ratio 8.75x
Best for: income & stability and long-term compounding
ARRY
Array Technologies, Inc.
The Growth Play

ARRY is the clearest fit if your priority is growth exposure.

  • Rev growth 40.2%, EPS growth 62.6%, 3Y rev CAGR -7.8%
  • 40.2% revenue growth vs ABVX's -100.0%
  • Lower P/E (10.2x vs 25.2x)
Best for: growth exposure
KO
The Coca-Cola Company
The Quality Compounder

KO has the current edge in this matchup, primarily because of its strength in quality and dividends.

  • 27.8% margin vs ARRY's -5.6%
  • 2.5% yield; 56-year raise streak; the other 2 pay no meaningful dividend
  • 13.1% ROA vs ABVX's -143.2%
Best for: quality and dividends
See the full category breakdown
CategoryWinnerWhy
GrowthARRY logoARRY40.2% revenue growth vs ABVX's -100.0%
ValueARRY logoARRYLower P/E (10.2x vs 25.2x)
Quality / MarginsKO logoKO27.8% margin vs ARRY's -5.6%
Stability / SafetyABVX logoABVXBeta 1.02 vs ARRY's 2.34, lower leverage
DividendsKO logoKO2.5% yield; 56-year raise streak; the other 2 pay no meaningful dividend
Momentum (1Y)ABVX logoABVX+12.6% vs ARRY's -4.1%
Efficiency (ROA)KO logoKO13.1% ROA vs ABVX's -143.2%

ABVX vs ARRY vs KO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

Discover the Renewable Energy Stocks Theme

These companies are key players in the Renewable Energy Stocks ecosystem. See how they stack up against the rest of the sector.

Explore Theme
ABVXAbivax S.A.

Segment breakdown not available.

ARRYArray Technologies, Inc.

Segment breakdown not available.

KOThe Coca-Cola Company
FY 2025
Pacific
84.6%$31.6B
Bottling investments
15.4%$5.7B

ABVX vs ARRY vs KO — Financial Metrics

Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLKOLAGGINGARRY

Income & Cash Flow (Last 12 Months)

KO leads this category, winning 6 of 6 comparable metrics.

KO and ABVX operate at a comparable scale, with $49.3B and $0 in trailing revenue. KO is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to ARRY's -5.6%. On growth, KO holds the edge at +12.1% YoY revenue growth, suggesting stronger near-term business momentum.

MetricABVX logoABVXAbivax S.A.ARRY logoARRYArray Technologie…KO logoKOThe Coca-Cola Com…
RevenueTrailing 12 months$0$1.2B$49.3B
EBITDAEarnings before interest/tax-$327M$95M$15.5B
Net IncomeAfter-tax profit-$427M-$67M$13.7B
Free Cash FlowCash after capex-$250M$58M$12.6B
Gross MarginGross profit ÷ Revenue+23.0%+61.7%
Operating MarginEBIT ÷ Revenue+4.5%+29.3%
Net MarginNet income ÷ Revenue-5.6%+27.8%
FCF MarginFCF ÷ Revenue+4.8%+25.5%
Rev. Growth (YoY)Latest quarter vs prior year-26.1%+12.1%
EPS Growth (YoY)Latest quarter vs prior year-40.0%-7.0%+18.2%
KO leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

ARRY leads this category, winning 5 of 6 comparable metrics.

On an enterprise value basis, ARRY's 12.7x EV/EBITDA is more attractive than KO's 26.4x.

MetricABVX logoABVXAbivax S.A.ARRY logoARRYArray Technologie…KO logoKOThe Coca-Cola Com…
Market CapShares × price$6.6B$1.1B$355.2B
Enterprise ValueMkt cap + debt − cash$6.1B$1.7B$390.4B
Trailing P/EPrice ÷ TTM EPS-18.79x-10.21x27.15x
Forward P/EPrice ÷ next-FY EPS est.10.24x25.24x
PEG RatioP/E ÷ EPS growth rate2.43x
EV / EBITDAEnterprise value multiple12.67x26.36x
Price / SalesMarket cap ÷ Revenue0.89x7.41x
Price / BookPrice ÷ Book value/share13.35x4.36x10.39x
Price / FCFMarket cap ÷ FCF14.36x67.07x
ARRY leads this category, winning 5 of 6 comparable metrics.

Profitability & Efficiency

KO leads this category, winning 6 of 9 comparable metrics.

KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $-3 for ABVX. ABVX carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to ARRY's 2.94x. On the Piotroski fundamental quality scale (0–9), KO scores 7/9 vs ABVX's 3/9, reflecting strong financial health.

MetricABVX logoABVXAbivax S.A.ARRY logoARRYArray Technologie…KO logoKOThe Coca-Cola Com…
ROE (TTM)Return on equity-3.0%-20.6%+41.1%
ROA (TTM)Return on assets-143.2%-4.4%+13.1%
ROICReturn on invested capital+9.0%+15.8%
ROCEReturn on capital employed-77.7%+8.2%+17.3%
Piotroski ScoreFundamental quality 0–9357
Debt / EquityFinancial leverage0.07x2.94x1.33x
Net DebtTotal debt minus cash-$484M$522M$35.2B
Cash & Equiv.Liquid assets$516M$244M$10.3B
Total DebtShort + long-term debt$32M$766M$45.5B
Interest CoverageEBIT ÷ Interest expense-14.16x-2.42x10.70x
KO leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

ABVX leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in ABVX five years ago would be worth $121,530 today (with dividends reinvested), compared to $4,613 for ARRY. Over the past 12 months, ABVX leads with a +1259.4% total return vs ARRY's -4.1%. The 3-year compound annual growth rate (CAGR) favors ABVX at 129.9% vs ARRY's -30.8% — a key indicator of consistent wealth creation.

MetricABVX logoABVXAbivax S.A.ARRY logoARRYArray Technologie…KO logoKOThe Coca-Cola Com…
YTD ReturnYear-to-date-24.6%-23.0%+20.2%
1-Year ReturnPast 12 months+1259.4%-4.1%+17.4%
3-Year ReturnCumulative with dividends+1115.3%-66.8%+46.9%
5-Year ReturnCumulative with dividends+1115.3%-53.9%+63.6%
10-Year ReturnCumulative with dividends+1115.3%-79.6%+120.9%
CAGR (3Y)Annualised 3-year return+129.9%-30.8%+13.7%
ABVX leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

KO leads this category, winning 2 of 2 comparable metrics.

KO is the less volatile stock with a -0.15 beta — it tends to amplify market swings less than ARRY's 2.34 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KO currently trades 98.2% from its 52-week high vs ARRY's 60.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricABVX logoABVXAbivax S.A.ARRY logoARRYArray Technologie…KO logoKOThe Coca-Cola Com…
Beta (5Y)Sensitivity to S&P 5001.02x2.34x-0.15x
52-Week HighHighest price in past year$148.83$12.23$84.04
52-Week LowLowest price in past year$5.69$5.39$65.35
% of 52W HighCurrent price vs 52-week peak+67.8%+60.9%+98.2%
RSI (14)Momentum oscillator 0–10041.934.965.7
Avg Volume (50D)Average daily shares traded1.5M5.2M12.6M
KO leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

KO leads this category, winning 1 of 1 comparable metric.

Analyst consensus: ABVX as "Buy", ARRY as "Buy", KO as "Buy". Consensus price targets imply 31.5% upside for ARRY (target: $10) vs 4.6% for KO (target: $86). KO is the only dividend payer here at 2.47% yield — a key consideration for income-focused portfolios.

MetricABVX logoABVXAbivax S.A.ARRY logoARRYArray Technologie…KO logoKOThe Coca-Cola Com…
Analyst RatingConsensus buy/hold/sellBuyBuyBuy
Price TargetConsensus 12-month target$131.22$9.80$86.29
# AnalystsCovering analysts122848
Dividend YieldAnnual dividend ÷ price+2.5%
Dividend StreakConsecutive years of raises156
Dividend / ShareAnnual DPS$2.04
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+0.2%
KO leads this category, winning 1 of 1 comparable metric.
Key Takeaway

KO leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ARRY leads in 1 (Valuation Metrics).

Best OverallThe Coca-Cola Company (KO)Leads 4 of 6 categories
Loading custom metrics...

ABVX vs ARRY vs KO: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is ABVX or ARRY or KO a better buy right now?

For growth investors, Array Technologies, Inc.

(ARRY) is the stronger pick with 40. 2% revenue growth year-over-year, versus 1. 9% for The Coca-Cola Company (KO). The Coca-Cola Company (KO) offers the better valuation at 27. 1x trailing P/E (25. 2x forward), making it the more compelling value choice. Analysts rate Abivax S. A. (ABVX) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ABVX or ARRY or KO?

On forward P/E, Array Technologies, Inc.

is actually cheaper at 10. 2x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — ABVX or ARRY or KO?

Over the past 5 years, Abivax S.

A. (ABVX) delivered a total return of +1115%, compared to -53. 9% for Array Technologies, Inc. (ARRY). Over 10 years, the gap is even starker: ABVX returned +1115% versus ARRY's -79. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ABVX or ARRY or KO?

By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.

15β versus Array Technologies, Inc. 's 2. 34β — meaning ARRY is approximately -1681% more volatile than KO relative to the S&P 500. On balance sheet safety, Abivax S. A. (ABVX) carries a lower debt/equity ratio of 7% versus 3% for Array Technologies, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — ABVX or ARRY or KO?

By revenue growth (latest reported year), Array Technologies, Inc.

(ARRY) is pulling ahead at 40. 2% versus 1. 9% for The Coca-Cola Company (KO). On earnings-per-share growth, the picture is similar: Array Technologies, Inc. grew EPS 62. 6% year-over-year, compared to -66. 1% for Abivax S. A.. Over a 3-year CAGR, KO leads at 3. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ABVX or ARRY or KO?

The Coca-Cola Company (KO) is the more profitable company, earning 27.

3% net margin versus -4. 1% for Array Technologies, Inc. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus 0. 0% for ABVX. At the gross margin level — before operating expenses — KO leads at 61. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ABVX or ARRY or KO more undervalued right now?

On forward earnings alone, Array Technologies, Inc.

(ARRY) trades at 10. 2x forward P/E versus 25. 2x for The Coca-Cola Company — 15. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ARRY: 31. 5% to $9. 80.

08

Which pays a better dividend — ABVX or ARRY or KO?

In this comparison, KO (2.

5% yield) pays a dividend. ABVX, ARRY do not pay a meaningful dividend and should not be held primarily for income.

09

Is ABVX or ARRY or KO better for a retirement portfolio?

For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

15), 2. 5% yield, +120. 9% 10Y return). Array Technologies, Inc. (ARRY) carries a higher beta of 2. 34 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KO: +120. 9%, ARRY: -79. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ABVX and ARRY and KO?

These companies operate in different sectors (ABVX (Healthcare) and ARRY (Energy) and KO (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ABVX is a small-cap quality compounder stock; ARRY is a small-cap high-growth stock; KO is a large-cap quality compounder stock. KO pays a dividend while ABVX, ARRY do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.